Journal
ACS MEDICINAL CHEMISTRY LETTERS
Volume 10, Issue 2, Pages 186-190Publisher
AMER CHEMICAL SOC
DOI: 10.1021/acsmedchemlett.8b00391
Keywords
Drug discovery; melanoma; marine natural products; medicinal chemistry; seriniquinone; dermcidin
Categories
Funding
- NIH, National Cancer Institute [CA 044848]
- Taubman Foundation
- FAPESP [2015/17117-6, 2016/10854-5, 2018/07661-6]
- Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [18/07661-6] Funding Source: FAPESP
Ask authors/readers for more resources
Seriniquinone, a marine natural product, displayed potent cytotoxicity and selectivity against melanoma cancer cells. This selectivity, combined with a novel mode of action (MOA), prompted studies to translate a pharmacologically relevant lead. Herein, we report on structure-activity relationships (SARs), and provide a strategy to prepare analogues that retain activity and offer an improved water solubility and isomeric purity. From intermediates made on a gram-scale, derivatives were prepared and evaluated for their antiproliferation activity and melanoma selectivity. Overall these studies provide methods to install side chain motifs that demonstrate a common, and yet unique, biological profile.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available